Trials / Conditions / Primary Hyperoxaluria Type 1

Primary Hyperoxaluria Type 1

9 registered clinical trials studyying Primary Hyperoxaluria Type 1 — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Evaluation of the Efficacy and Safety of Stiripentol in Patients 6 Years and Older With Primary Hyperoxaluria NCT06465472	Biocodex	Phase 3
Completed	Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal Function NCT05001269	Dicerna Pharmaceuticals, Inc., a Novo Nordisk company	Phase 2
Active Not Recruiting	BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1) NCT04982393	Alnylam Pharmaceuticals	—
Recruiting	Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD NCT04580420	Dicerna Pharmaceuticals, Inc., a Novo Nordisk company	Phase 2
Completed	A Study to Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1 NCT04152200	Alnylam Pharmaceuticals	Phase 3
Enrolling By Invitation	Early Check: Expanded Screening in Newborns NCT03655223	RTI International	—
Completed	Proteomics of Primary Hyperoxaluria Type 1 NCT03067142	Ann & Robert H Lurie Children's Hospital of Chicago	—
Terminated	A Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 (PH1) NCT02795325	Dicerna Pharmaceuticals, Inc., a Novo Nordisk company	Phase 1
Completed	IDENTIFICATION OF A MULTI-ANALYTE PROFILE FOR PRIMARY HYPEROXALURIA AND COMPARISON WITH HEALTHY SIBLINGS AND I NCT02830009	Hospices Civils de Lyon	N/A